PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+16.73%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$13.6B
AUM Growth
+$1.09B
(+8.7%)
Cap. Flow
-$470M
Cap. Flow
% of AUM
-3.44%
Top 10 Holdings %
Top 10 Hldgs %
26.38%
Holding
338
New
29
Increased
113
Reduced
120
Closed
45
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$100M |
| 2 |
Uber
UBER
|
$92.9M |
| 3 |
Baidu
BIDU
|
$87M |
| 4 |
ON Semiconductor
ON
|
$70.2M |
| 5 |
Inspire Medical Systems
INSP
|
$62.9M |
Top Sells
| 1 |
Arch Capital
ACGL
|
$80.1M |
| 2 |
Microsoft
MSFT
|
$75.1M |
| 3 |
Penumbra
PEN
|
$63.4M |
| 4 |
Becton Dickinson
BDX
|
$63M |
| 5 |
BILL Holdings
BILL
|
$62.3M |
Sector Composition
| 1 | Technology | 40.68% |
| 2 | Healthcare | 23.35% |
| 3 | Financials | 18.62% |
| 4 | Communication Services | 7% |
| 5 | Consumer Discretionary | 5.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Paycom
PAYC
$12.6B
| $16.5M | 0.11% |
54,381
+34,698
| +176% | +$10.5M |
|
152
MSCI
MSCI
$42.9B
| $16M | 0.1% |
28,604
+4,043
| +16% | +$2.26M |
|
153
Cannae Holdings
CNNE
$1.09B
| $15.3M | 0.1% |
758,395
+4,181
| +0.6% | +$84.4K |
|
154
Veeva Systems
VEEV
$44.7B
| $15.1M | 0.1% |
81,919
-20,132
| -20% | -$3.7M |
|
155
Viridian Therapeutics
VRDN
$1.53B
| $14M | 0.09% |
+550,000
| New | +$14M |
|
156
Merus
MRUS
$5.1B
| $13.8M | 0.09% |
750,000
| – | – |
|
157
Toronto Dominion Bank
TD
$127B
| $13.4M | 0.09% |
224,344
-9,100
| -4% | -$545K |
|
158
Intuit
INTU
$188B
| $13.3M | 0.09% |
29,836
-10,950
| -27% | -$4.88M |
|
159
Teck Resources
TECK
$16.8B
| $13.2M | 0.09% |
362,326
+21,067
| +6% | +$769K |
|
160
Liberty Media Series C
FWONK
$25.2B
| $13.2M | 0.09% |
182,337
+26,959
| +17% | +$1.95M |
|
161
Tenet Healthcare
THC
$17.3B
| $13.1M | 0.09% |
220,175
-1,818
| -0.8% | -$108K |
|
162
Elevance Health
ELV
$70.6B
| $13M | 0.08% |
28,326
-12,010
| -30% | -$5.52M |
|
163
Norfolk Southern
NSC
$62.3B
| $12.8M | 0.08% |
60,206
-775
| -1% | -$164K |
|
164
Cognex
CGNX
$7.55B
| $12.7M | 0.08% |
255,573
+88,332
| +53% | +$4.38M |
|
165
Service Corp International
SCI
$10.9B
| $12.5M | 0.08% |
182,395
+4,630
| +3% | +$318K |
|
166
Flywire
FLYW
$1.59B
| $12.4M | 0.08% |
421,261
-209,145
| -33% | -$6.14M |
|
167
Denali Therapeutics
DNLI
$2.26B
| $11.6M | 0.08% |
+505,000
| New | +$11.6M |
|
168
AptarGroup
ATR
$9.13B
| $10.9M | 0.07% |
91,998
-39,434
| -30% | -$4.66M |
|
|
RCM
169
DELISTED
R1 RCM Inc. Common Stock
RCM
| $10.8M | 0.07% |
719,408
-169,898
| -19% | -$2.55M |
|
|
AKYA
170
DELISTED
Akoya BioSciences
AKYA
| $10.8M | 0.07% |
1,315,470
| – | – |
|
171
Axon Enterprise
AXON
$57.2B
| $10.6M | 0.07% |
47,141
+10,191
| +28% | +$2.29M |
|
172
Ametek
AME
$43.3B
| $10.5M | 0.07% |
72,168
-50,906
| -41% | -$7.4M |
|
173
Ovintiv
OVV
$10.6B
| $10.2M | 0.07% |
283,388
-182,594
| -39% | -$6.59M |
|
174
Vertiv
VRT
$47.4B
| $10.2M | 0.07% |
711,000
+152,500
| +27% | +$2.18M |
|
175
Y-mAbs Therapeutics
YMAB
$390M
| $9.98M | 0.06% |
1,991,929
| – | – |
|